By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

H LUNDBECK A/S (($HLUYY)) announced an update on their ongoing clinical study. H. Lundbeck A/S is currently conducting a clinical trial titled ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

HBAR could recover above $0.25 amid SWIFT blockchain trials, but the current market correction could affect its comeback.

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

D Molecular Therapeutics advances 4D-150 for wet AMD and DME, revealing promising trial results and regulatory progress for ...

Baptist Health Hardin has become the first hospital in the world to begin human trials of new breast imaging technology to ...

The vaccine would train the immune system to fight cancer-causing mutations, according to new research from UCLA Health.

As part of the treatment trial, Jay does chemotherapy every other week for six months. Access to clinical trials is offered ...

Aclaris Therapeutics Inc. (NASDAQ: ACRS) is one of the most promising penny stocks under $5. On July 29, Aclaris Therapeutics ...